Publications by authors named "Josef Brock"

Claim this Profile
E
Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes.
Hermann Walzel, Abdelgawad A Fahmi, Mohamed A Eldesouky, Ehab F Abou-Eladab, Grit Waitz, Josef Brock

Glycobiology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of early gene expression induced by erythropoietin receptor structural variants.
Tom Büchse, Holger Prietzsch, Tilo Sasse, Sandra Körbel, Gunnar Stigge, Josef Brock

J Biol Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoprotein profiling of erythropoietin receptor- dependent pathways using different proteomic strategies.
Sandra Körbel, Tom Büchse, Holger Prietzsch, Tilo Sasse, Michael Schümann, Josef Brock

Proteomics· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of galectin-1 on regulation of progesterone production in granulosa cells from pig ovaries in vitro.
Hermann Walzel, Josef Brock, Ralf Pöhland, Jens Vanselow, Wolfgang Tomek

Glycobiology· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 prevents anti-CD4 mAb-induced tolerance but cannot reverse established tolerance in a rat kidney transplantation model.
Grit Schroeder, Kirsten Risch, Katja Kotsch, Anja Siepert, Josef Brock

Am J Transplant· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes.
Hermann Walzel, Matthias Blach, Jun Hirabayashi, Yoichiro Arata, Ken-ichi Kasai, Josef Brock

Cell Signal· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-alpha inhibits cell cycle progression by Ba/F3 cells through the antagonisation of interleukin-3 effects on key regulators of G(1)/S transition.
Holger Prietzsch, Josef Brock, Hans-Dieter Kleine, Stefan Liebe, Robert Jaster

Cell Signal· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bag-1 up-regulation in anti-CD4 mAb-treated allo-activated T cell confers resistance to activation-induced cell death (AICD).
Birgit Sawitzki, Manfred Lehmann, Katrin Vogt, Martina Seifert, Kirsten Risch, Josef Brock

Transpl Immunol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone morphogenetic protein-7 (OP1) and transforming growth factor-beta1 modulate 1,25(OH)2-vitamin D3-induced differentiation of human osteoblasts.
Annegret Eichner, Josef Brock, Carl-Henrik Heldin, Serhiy Souchelnytskyi

Exp Cell Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis.
Birgit Sawitzki, Manfred Lehmann, Katrin Vogt, Kirsten Risch, Josef Brock

Eur J Immunol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis